Logo Logo Logo Logo Logo
  • COMPANY
    • About Us
    • Executive Team
    • Board of Directors
    • Scientific Advisory Board
    • Business Development
    • Main Investors
    • Contact Us
  • TECHNOLOGIES
    • OPTIREACH Technology
    • Antibody Fragment Technology
  • PIPELINE
    • Overview
    • OCS-01 Diabetic Macular Edema
    • OCS-01 Post Cataract Surgery Inflammation
    • OCS-02 Uveitis
    • OCS-02 Dry Eye
    • OCS-05 Glaucoma
  • NEWS
    • Press releases
    • Articles
  • CAREERS

  • COMPANY

    • About Us
    • Executive Team
    • Board of Directors
    • Scientific Advisory Board
    • Business Development
    • Main Investors
    • Contact Us

  • TECHNOLOGIES

    • OPTIREACH Technology
    • Antibody Fragment Technology

  • PIPELINE

    • Overview
    • OCS-01 Diabetic Macular Edema
    • OCS-01 Post Cataract Surgery Inflammation
    • OCS-02 Uveitis
    • OCS-02 Dry Eye
    • OCS-05 Glaucoma

  • NEWS

    • Press releases
    • Articles
  • CAREERS
Contact us

Oculis Switzerland
Corporate Headquarters
EPFL Innovation Park Building D
Route J-D. Colladon
1015 Lausanne
Switzerland

+41 21 711 3970

 

info@oculis.com

Copyright © 2022 Oculis SA.

 

    © Oculis – Privacy Policy – Terms of Use  – Cookie Policy    

    © L’autreagence 2019 – 2022